A
AMT Medical
Developing minimally invasive technology for coronary artery bypass surgery
About AMT Medical
AMT Medical is a Dutch medtech company focused on revolutionizing coronary artery bypass grafting (CABG) through a minimally invasive approach. The company is developing a proprietary surgical technology called ELANA (Excimer Laser Assisted Non-Occlusive Anastomosis), designed to simplify and enhance the bypass procedure without the need for stopping the heart or using a heart-lung machine.
Read full description
Traditional open-heart bypass surgery involves significant trauma, long recovery times, and substantial risk. AMT Medical’s ELANA technology enables off-pump, minimally invasive bypass surgery by allowing surgeons to create a connection between blood vessels using a laser and specialized connector—without clamping or interrupting blood flow. This method reduces the need for full sternotomy and can be performed through small incisions, resulting in shorter hospital stays, less pain, and faster recovery for patients.
AMT Medical collaborates closely with cardiac surgeons, researchers, and hospitals across Europe to validate and refine its technology through clinical studies. The company’s goal is to make minimally invasive CABG the new standard of care for patients with coronary artery disease, particularly those who are high-risk or not ideal candidates for traditional procedures.
At a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Ede, Netherlands
- Employees
- 39
- Open positions
- 1
- Dealroom signal
- 86.7/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Surgery, Cardiology and cardiovascular, EIC, Investor Network (EIT Health), Investor Network 2019 (EIT Health), EIC Fund, EIT Health, Hard Tech
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning AMT Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Apr 2025 | $25M | $100M | Oost NL - Eastern Netherlands Regional Development Agency · EIC Fund · Invest-NL | ↗ |
| EARLY VC✓Equity / VC | Mar 2022 | $0 | — | EIC Fund | — |
Growth signals
Latest recorded traffic for AMT Medical is 60 monthly website visits, down 90.5% over the last three months. AMT Medical's team grew 30% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Utrecht Holdings
Nextgen Ventures- HIHorizon 2020 FTI (Fast Track to Innovation)
European Regional Development Fund
European Innovation Council
Series A3 investors entered at this stage
Oost NL - Eastern Netherlands Regional Development Agency
EIC Fund
Invest-NL
Other known investors2 additional known investors
EIT Health
UtrechtInc
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about AMT Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See AMT Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.